Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.77 USD | +4.84% | +1.71% | -8.80% |
Apr. 22 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 15 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Financials (USD)
Sales 2021 | 172M | Sales 2022 | 317M | Capitalization | 380M |
---|---|---|---|---|---|
Net income 2021 | -8M | Net income 2022 | 35M | EV / Sales 2021 | 3.44 x |
Net cash position 2021 | 67.84M | Net Debt 2022 | 10.19M | EV / Sales 2022 | 1.23 x |
P/E ratio 2021 |
-77
x | P/E ratio 2022 |
10.7
x | Employees | 134 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 65.14% |
Latest transcript on Eagle Pharmaceuticals, Inc.
1 day | +4.84% | ||
1 week | +1.71% | ||
Current month | -8.97% | ||
1 month | -6.10% | ||
3 months | +0.85% | ||
6 months | -63.89% | ||
Current year | -8.80% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Graves
CEO | Chief Executive Officer | 61 | 13-10-31 |
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 07-02-28 |
Ryan Debski
CMP | Compliance Officer | - | 21-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 07-02-28 |
Jennifer Simpson
BRD | Director/Board Member | 55 | 19-08-27 |
Richard Edlin
BRD | Director/Board Member | 63 | 17-03-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.54% | 29 M€ | -3.61% | ||
0.25% | 27 M€ | -4.16% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 4.55 | -1.30% | 283,208 |
24-04-19 | 4.61 | +2.90% | 59,516 |
24-04-18 | 4.48 | +2.05% | 135,741 |
24-04-17 | 4.39 | -6.40% | 109,204 |
24-04-16 | 4.69 | -9.81% | 161,336 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-8.80% | 59.09M | |
+12.97% | 9.18B | |
-16.33% | 4.78B | |
+6.40% | 3.87B | |
+26.98% | 3.73B | |
+28.27% | 2.52B | |
-26.55% | 2.27B | |
-25.02% | 2.21B | |
+5.82% | 1.95B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- EGRX Stock